AWM
GILD icon

Avior Wealth Management’s Gilead Sciences GILD Stock Holding History

Avior Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$831K Sell
7,098
-2,529
-26% -$333K 0.02% 400
2026
Q1 		$1.26M Buy
9,627
+1,511
+19% +$212K 0.04% 308
2025
Q4 		$935K Buy
8,116
+230
+3% +$28K 0.03% 326
2025
Q3 		$830K Buy
7,886
+356
+5% +$40.5K 0.03% 335
2025
Q2 		$790K Buy
7,530
+2,739
+57% +$291K 0.03% 333
2025
Q1 		$490K Sell
4,791
-7,760
-62% -$801K 0.02% 413
2024
Q4 		$1.14M Buy
12,551
+3,129
+33% +$282K 0.04% 261
2024
Q3 		$782K Buy
9,422
+108
+1% +$8.24K 0.03% 337
2024
Q2 		$653K Sell
9,314
-1,382
-13% -$92.2K 0.03% 368
2024
Q1 		$791K Buy
10,696
+2,167
+25% +$167K 0.04% 338
2023
Q4 		$687K Sell
8,529
-580
-6% -$45.1K 0.04% 270
2023
Q3 		$687K Sell
9,109
-515
-5% -$39.6K 0.05% 257
2023
Q2 		$744K Sell
9,624
-474
-5% -$37.8K 0.05% 252
2023
Q1 		$832K Buy
10,098
+3,414
+51% +$283K 0.06% 228
2022
Q4 		$564K Hold
6,684
– – 0.04% 275
2022
Q3 		$435K Buy
6,684
+84
+1% +$5.3K 0.04% 303
2022
Q2 		$430K Hold
6,600
– – 0.04% 280
2022
Q1 		$418K Hold
6,600
– – 0.04% 334
2021
Q4 		$487K Buy
6,600
+5,000
+313% +$344K 0.04% 332
2021
Q3 		$123K Buy
1,600
+70
+5% +$4.92K 0.01% 465
2021
Q2 		$118K Buy
1,530
+10
+0.7% +$668 0.01% 450
2021
Q1 		$117K Sell
1,520
-115
-7% -$7.42K 0.01% 450
2020
Q4 		$123K Sell
1,635
-1,597
-49% -$96.4K 0.02% 421
2020
Q3 		$225K Hold
3,232
– – 0.03% 362
2020
Q2 		$250K Sell
3,232
-3,953
-55% -$303K 0.04% 357
2020
Q1 		$541K Buy
7,185
+85
+1% +$5.87K 0.11% 189
2019
Q4 		$479K Hold
7,100
– – 0.08% 231
2019
Q3 		$470K Sell
7,100
-64
-0.9% -$4.18K 0.08% 230
2019
Q2 		$499K Buy
7,164
+65
+0.9% +$4.28K 0.09% 208
2019
Q1 		$479K Hold
7,099
– – 0.1% 199
2018
Q4 		$465K Sell
7,099
-118
-2% -$8.25K 0.11% 174
2018
Q3 		$559K Buy
7,217
+1
+0% +$76 0.12% 167
2018
Q2 		$522K Sell
7,216
-19
-0.3% -$1.34K 0.12% 164
2018
Q1 		$550K Sell
7,235
-399
-5% -$31.7K 0.13% 157
2017
Q4 		$556K Buy
7,634
+4,421
+138% +$336K 0.12% 160
2017
Q3 		$257K Buy
3,213
+48
+2% +$3.67K 0.08% 128
2017
Q2 		$235K Sell
3,165
-74
-2% -$4.92K 0.1% 111
2017
Q1 		$235K Sell
3,239
-13,820
-81% -$972K 0.08% 139
2016
Q4 		$1.24M Buy
17,059
+421
+3% +$31.3K 0.46% 79
2016
Q3 		$1.31M Buy
16,638
+2,115
+15% +$172K 0.52% 66
2016
Q2 		$1.21M Buy
14,523
+1,192
+9% +$106K 0.51% 67
2016
Q1 		$1.23M Buy
13,331
+1,245
+10% +$112K 0.54% 58
2015
Q4 		$1.22M Buy
12,086
+435
+4% +$45.3K 0.67% 39
2015
Q3 		$1.15M Buy
11,651
+9,191
+374% +$1.02M 0.67% 37
2015
Q2 		$286K Sell
2,460
-133
-5% -$14.5K 0.22% 53
2015
Q1 		$255K Buy
2,593
+1,705
+192% +$173K 0.2% 57
2014
Q4 		$84K Hold
888
– – 0.07% 104
2014
Q3 		$95K Buy
888
+525
+145% +$51.4K 0.08% 97
2014
Q2 		$60K Sell
363
-400
-52% -$31.1K 0.05% 120
2014
Q1 		$54K Buy
+763
New +$59.8K 0.05% 120

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Avior Wealth Management's GILD Position: Q2 2026 in Review

Avior Wealth Management reduced its Gilead Sciences (GILD) stake by 26% in Q2 2026, selling an estimated $333K and leaving 7,098 shares worth $831K. The position accounts for 0.02% of the portfolio, ranked #400.

Avior Wealth Management first reported a position in GILD in Q1 2014 and has held it in 50 quarters since. The position peaked at $1.31M in Q3 2016. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Avior Wealth Management held 7,098 shares of Gilead Sciences worth $831K as of Q2 2026.
  • Avior Wealth Management sold 2,529 Gilead Sciences shares in Q2 2026, an estimated $333K.
  • Gilead Sciences made up 0.02% of Avior Wealth Management's portfolio in Q2 2026, its #400 holding.
  • Avior Wealth Management first reported a position in Gilead Sciences in Q1 2014 and has held it in 50 quarters since.
  • Avior Wealth Management's Gilead Sciences position peaked at $1.31M in Q3 2016.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Avior Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.